Neuraxis (NRXS) Interest & Investment Income (2023)

Neuraxis (NRXS) posted Interest & Investment Income of $2103.0 for Q3 2023.

Neuraxis (NRXS) Interest & Investment Income (2023) Analysis & Trends

Neuraxis has reported Interest & Investment Income for 1 years, with the latest figure at $2103.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Int & Inv Inc (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	120.60 Mn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-48.00 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	48.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	67.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	27.90 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	28.14 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	10.98 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	5.13 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	115.94 Mn
10	Neuraxis	75.51 Mn	67.18 Mn	-	-

Download Data

Date	Value
Sep 30, 2023	2,103.00